fda warning bpc 157 peptide products New Details 157 FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides Lack Reliable Safety Information, Watchdog Warns